{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:39:54Z","timestamp":1785314394254,"version":"3.55.0"},"reference-count":52,"publisher":"Publicidad Permanyer, SLU","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Cardiolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.acmx.2014.11.005","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T03:49:11Z","timestamp":1424231351000},"page":"124-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prote\u00edna C ultrasensible como factor independiente de riesgo en poblaci\u00f3n con y sin antecedentes cardiovasculares"],"prefix":"10.24875","volume":"85","author":[{"given":"Viviana","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Augustovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Pich\u00f3n-Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Garc\u00eda-Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Comand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10499","reference":[{"key":"10.1016\/j.acmx.2014.11.005_bib0005","unstructured":"Indicadores b\u00e1sicos 2011. Ministerio de Salud de Argentina 2011 [consultado 14 Oct 2012]. Disponible en: http:\/\/www.deis.gov.ar\/publicaciones\/archivos\/indicadores_2010.pdf."},{"key":"10.1016\/j.acmx.2014.11.005_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.carpath.2012.03.001","article-title":"Cardiovascular risk and atherosclerosis prevention","volume":"22","author":"Frohlich","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","article-title":"The phenomenon of the acute phase response","volume":"389","author":"Kushner","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.acmx.2014.11.005_bib0025","first-page":"414","article-title":"Estudio inmunol\u00f3gico en pacientes con infarto agudo de miocardio: An\u00e1lisis inmuno-serol\u00f3gicos i [Immunologic study in patients with acute myocardial infarct. I. Immuno-serologic analysis]","volume":"48","author":"Martinez","year":"1978","journal-title":"Arch Inst Cardiol Mex"},{"key":"10.1016\/j.acmx.2014.11.005_bib0030","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics [consultado 14 Oct 2012]. Disponible en: http:\/\/www.cdc.gov\/heartdisease\/"},{"key":"10.1016\/j.acmx.2014.11.005_bib0035","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N EngL J Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0040","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0050","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0055","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2046-4053-1-36","article-title":"Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior","volume":"1","author":"Cheung","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.acmx.2014.11.005_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0075","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.0b013e3181bd10bc","article-title":"High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study","volume":"73","author":"Elkind","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.acmx.2014.11.005_bib0080","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/ATVBAHA.110.208785","article-title":"C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: The PRIME study","volume":"30","author":"Empana","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.acmx.2014.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1538-7836.2009.03574.x","article-title":"Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men","volume":"7","author":"Wannamethee","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acmx.2014.11.005_bib0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2011.05.015","article-title":"Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women","volume":"129","author":"Wennberg","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.acmx.2014.11.005_bib0100","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/hrt.2009.170134","article-title":"Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: The EPIC-Norfolk prospective population study","volume":"95","author":"Rana","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.acmx.2014.11.005_bib0105","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1532-5415.2009.02625.x","article-title":"Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: The three-city study","volume":"58","author":"Straczek","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.acmx.2014.11.005_bib0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0120","doi-asserted-by":"crossref","first-page":"e1000286","DOI":"10.1371\/journal.pmed.1000286","article-title":"Evaluating the quality of research into a single prognostic biomarker: A systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease","volume":"7","author":"Hemingway","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1373\/clinchem.2008.117192","article-title":"Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death","volume":"55","author":"Scirica","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.acmx.2014.11.005_bib0130","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation","volume":"120","author":"Park","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0135","doi-asserted-by":"crossref","first-page":"e1000099","DOI":"10.1371\/journal.pmed.1000099","article-title":"Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?","volume":"6","author":"Sattar","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/00365513.2010.538081","article-title":"High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: A prognostic study within the CLARICOR trial","volume":"71","author":"Harutyunyan","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.acmx.2014.11.005_bib0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/S0066-782X2011005000032","article-title":"C-Reactive protein and outcomes in acute coronary syndromes: A systematic review and meta-analysis","volume":"97","author":"Correia","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/hrt.2009.174912","article-title":"Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: A meta-analysis of longitudinal studies","volume":"96","author":"He","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.acmx.2014.11.005_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-010-0516-y","article-title":"Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: An analysis from the ACUITY trial","volume":"31","author":"Caixeta","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acmx.2014.11.005_bib0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2261-11-57","article-title":"B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: A prospective observational study from Salta Argentina","volume":"11","author":"Leon de la Fuente","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.acmx.2014.11.005_bib0165","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/eurheartj\/ehq468","article-title":"Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: Observations from the MERLIN-TIMI 36 trial","volume":"32","author":"Scirica","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acmx.2014.11.005_bib0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-151-7-200910060-00008","article-title":"Using nontraditional risk factors in coronary heart disease risk assessment: U.S Preventive Services Task Force recommendation statement","volume":"151","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acmx.2014.11.005_bib0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0180","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/CIR.0b013e3182051bab","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0185","first-page":"e1","article-title":"Gu\u00eda europea sobre prevenci\u00f3n de la enfermedad cardiovascular en la pr\u00e1ctica cl\u00ednica (versi\u00f3n 2012)","volume":"65","author":"Perk","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0190","first-page":"220","article-title":"Ministry of health clinical practice guidelines: screening of cardiovascular disease and risk factors","volume":"52","author":"Goh","year":"2011","journal-title":"Singapore Med J"},{"key":"10.1016\/j.acmx.2014.11.005_bib0195","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acmx.2014.11.005_bib0200","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2014.11.005_bib0205","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acmx.2014.11.005_bib0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"60","author":"Jneid","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0215","unstructured":"National vascular disease prevention alliance. Guidelines for the assessment of absolute cardiovascular disease risk. 2009 [consultado 10 May 2013].Disponible en: http:\/\/www.heartfoundation.org.au\/SiteCollectionDocuments\/guidelines-Absolute-risk.pdf"},{"key":"10.1016\/j.acmx.2014.11.005_bib0220","unstructured":"Walsh J. Assessing cardiovascular disease risk with HS-C reactive protein. A technology assessment. California technology assessment forum 2009. Jun 2009 [consultado 14 Oct 2012]. Disponible en: http:\/\/ctaf.org\/reports\/assessing-cardiovascular-disease-risk-hs-c-reactive-protein"},{"key":"10.1016\/j.acmx.2014.11.005_bib0225","unstructured":"Aetna.Clinical Policy Bulletin: Cardiovascular disease risk tests [consultado 12 Nov 2012]. Available from: http:\/\/www.aetna.com\/cpb\/medical\/data\/300_399\/0381.html: USA; 2011"},{"key":"10.1016\/j.acmx.2014.11.005_bib0230","unstructured":"CIGNA medical coverage policy. Cardiac disease risk assesment: Emergying laboratory evaluation. 2010 [consultado 12 Nov 2012]. Disponible en: https:\/\/my.cigna.com\/teamsite\/health\/provider\/medical\/procedural\/coverage_positions\/medical\/mm_0137_coveragepositioncriteria_cardiac_disease_risk_laboratory_studies.pdf"},{"key":"10.1016\/j.acmx.2014.11.005_bib0235","unstructured":"Humana. Cardiovascular disease (CVD) risk testing (Laboratory). Medical coverage policy [consultado 12 Nov 2012.]. Disponible en: http:\/\/apps.humana.com\/tad\/tad_new\/home.aspx"},{"key":"10.1016\/j.acmx.2014.11.005_bib0240","unstructured":"Blue cross of Idaho. High sensitivity C reactive protein. 2010 [consultado 12 Nov 2012]. Disponible en: https:\/\/www.bcidaho.com\/providers\/medical_policies\/med\/mp_20422.asp"},{"issue":"25 Pt B","key":"10.1016\/j.acmx.2014.11.005_bib0245","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0250","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.repc.2012.02.018","article-title":"[High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease]","volume":"31","author":"Silva","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.acmx.2014.11.005_bib0255","unstructured":"Burnett L, Terfolja T. Getting started on your literature review. A general guide for postgraduate research students. 2002 [consultado 14 Oct 2012]. Disponible en: http:\/\/www.lc.unsw.edu.au\/onlib\/pdf\/Litrev.pdf"},{"key":"10.1016\/j.acmx.2014.11.005_bib0260","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.1994.03520170077040","article-title":"Users\u2019 guides to the medical literature. VI. How to use an overview. Evidence-based medicine working group","volume":"272","author":"Oxman","year":"1994","journal-title":"JAMA"}],"container-title":["Archivos de Cardiolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1405994014001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1405994014001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.archivoscardiologia.com\/previos\/(2015)%20ACM%20Vol%2085.%202%20ABRIL-JUNIO\/ACMX_2015_85_2_124-135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T01:21:50Z","timestamp":1566350510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.archivoscardiologia.com\/previos\/(2015)%20ACM%20Vol%2085.%202%20ABRIL-JUNIO\/ACMX_2015_85_2_124-135.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1405994014001888"],"URL":"https:\/\/doi.org\/10.1016\/j.acmx.2014.11.005","relation":{},"ISSN":["1405-9940"],"issn-type":[{"value":"1405-9940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prote\u00edna C ultrasensible como factor independiente de riesgo en poblaci\u00f3n con y sin antecedentes cardiovasculares","name":"articletitle","label":"Article Title"},{"value":"Archivos de Cardiolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acmx.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez. Published by Masson Doyma M\u00e9xico S.A. All rights reserved.","name":"copyright","label":"Copyright"}]}}